Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clobazam plasma concentrations: pharmacokinetic study in healthy volunteers and data in epileptic patients.

Literature DB >> 7272180

Clobazam plasma concentrations: pharmacokinetic study in healthy volunteers and data in epileptic patients.

G Tedeschi, R Riva, A Baruzzi.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1981 PMID： 7272180 PMCID： PMC1402199 DOI： 10.1111/j.1365-2125.1981.tb01180.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

4 in total

1. Plasma levels of clobazam after three oral dosage forms in health subjects.

Authors: J J Vallner; T E Needham; H W Jun; W J Brown; J T Stewart; J A Kotzan; I L Honigberg
Journal: J Clin Pharmacol Date: 1978-07 Impact factor: 3.126

2. Kinetics and metabolism of clobazam in animals and man.

Authors: M Volz; O Christ; H M Kellner; H Kuch; H W Fehlhaber; D Gantz; P Hajdu; F Cavagna
Journal: Br J Clin Pharmacol Date: 1979 Impact factor: 4.335

3. Antiepileptic properties of clobazam, a 1-5 benzodiazepine, in man.

Authors: H Gastaut; M D Low
Journal: Epilepsia Date: 1979-08 Impact factor: 5.864

Review 4. Clobazam: a review of its pharmacological properties and therapeutic use in anxiety.

Authors: R N Brogden; R C Heel; T M Speight; G S Avery
Journal: Drugs Date: 1980-09 Impact factor: 9.546

4 in total

11 in total

Review 1. Clinical pharmacokinetics of non-opiate abused drugs.

Authors: U Busto; R Bendayan; E M Sellers
Journal: Clin Pharmacokinet Date: 1989-01 Impact factor: 6.447

Review 2. Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies.

Authors: Jose de Leon; Edoardo Spina; Francisco J Diaz
Journal: Ther Drug Monit Date: 2013-02 Impact factor: 3.681

3. PharmGKB summary: clobazam pathway, pharmacokinetics.

Authors: Rachel Huddart; J Steven Leeder; Russ B Altman; Teri E Klein
Journal: Pharmacogenet Genomics Date: 2018-04 Impact factor: 2.089

Review 4. Clobazam.

Authors: Yu-tze Ng; Stephen D Collins
Journal: Neurotherapeutics Date: 2007-01 Impact factor: 7.620

Clobazam plasma concentrations: pharmacokinetic study in healthy volunteers and data in epileptic patients.

1. Plasma levels of clobazam after three oral dosage forms in health subjects.

2. Kinetics and metabolism of clobazam in animals and man.

3. Antiepileptic properties of clobazam, a 1-5 benzodiazepine, in man.

Review 4. Clobazam: a review of its pharmacological properties and therapeutic use in anxiety.

Review 1. Clinical pharmacokinetics of non-opiate abused drugs.

Review 2. Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies.

3. PharmGKB summary: clobazam pathway, pharmacokinetics.

Review 4. Clobazam.

5. Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients.

Review 6. Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment.

7. The effect of cimetidine on the single dose pharmacokinetics of oral clobazam and N-desmethylclobazam.

Review 8. Clinical pharmacokinetics of the newer benzodiazepines.

9. Pharmacokinetics of N-desmethylclobazam in healthy volunteers and patients with epilepsy.

10. A physiologically based pharmacokinetic model for clobazam and stiripentol in adults and children.